Component

Small-intestinal mucosal GSH/GSSG ratio

Small-intestinal mucosal GSH/GSSG ratio. Species, exposure and limitations are retained in each linked claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. The cystine-theanine mixture restored the intestinal GSH/GSSG ratio during 5-fluorouracil exposure.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/theanine-research/34922485.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5828410d2c083fec47a3c7e1907b801a2dc616dbbb7e5ed36e59d503bceeb282", "start_char": 0, "end_char": 1703, "text_sha256": "5828410d2c083fec47a3c7e1907b801a2dc616dbbb7e5ed36e59d503bceeb282"}
    experimental_model
    Chemotherapy-associated intestinal injury experiment
    exposure
    Cystine plus theanine during 5-fluorouracil exposure
    limitations
    Combination product, not isolated theanine. Preservation of antitumor activity in the tested model does not establish compatibility with every human chemotherapy regimen.
    nutrient_topic
    L-Theanine research collection; topical membership is not evidence of a direct dietary effect. · L-Theanine
    organism
    Mice
    plain_language
    This result belongs to the tested two-ingredient mixture and its chemotherapy context.
    primary_references
    [theanine-p34922485] Oral administration of cystine and theanine attenuates 5-fluorouracil-induced intestinal mucositis and diarrhea by suppressing both glutathione level decrease and ROS production in the small intestine of mucositis mouse model. (2021). https://pubmed.ncbi.nlm.nih.gov/34922485/ DOI: 10.1186/s12885-021-09057-z
    tissue_or_cell_type
    Intestinal redox balance and crypt injury

    L-Theanine: metabolism, neural signaling, nutrient connections and human outcomes (2026-09-17) · lines 757–768

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Chemotherapy-associated intestinal injury experiment · source_derived_draft · unverified_draft

    ### theanine-ct-redox The cystine-theanine mixture restored the intestinal GSH/GSSG ratio during 5-fluorouracil exposure. Condition category: normal nutrient_topic: L-Theanine research collection; topical membership is not evidence of a direct dietary effect. plain_language: This result belongs to the tested two-ingredient mixture and its chemotherapy context. organism: Mice tissue_or_cell_type: Intestinal redox balance and crypt injury experimental_model: Chemotherapy-associated intestinal injury experiment limitations: Combination product, not isolated theanine. Preservation of antitumor activity in the tested model does not establish compatibility with every human chemotherapy regimen. exposure: Cystine plus theanine during 5-fluorouracil exposure evidence_span: {"source_cache": "artifacts/theanine-research/34922485.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5828410d2c083fec47a3c7e1907b801a2dc616dbbb7e5ed36e59d503bceeb282", "start_char": 0, "end_char": 1703, "text_sha256": "5828410d2c083fec47a3c7e1907b801a2dc616dbbb7e5ed36e59d503bceeb282"} [theanine-p34922485] Oral administration of cystine and theanine attenuates 5-fluorouracil-induced intestinal mucositis and diarrhea by suppressing both glutathione level decrease and ROS production in the small intestine of mucositis mouse model. (2021). https://pubmed.ncbi.nlm.nih.gov/34922485/ DOI: 10.1186/s12885-021-09057-z
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards